Loading insider details...
Beta
Latest Form 4 (Jun 5, 2026): Grant/Award of 19,676 BEAM shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 5, 2026 | Beam Therapeutics Inc. (BEAM) | Grant/Award | 19,676 | n/a |
| May 29, 2026 | Kyverna Therapeutics, Inc. (KYTX) | Tax Withholding | 4,194 | $36.0K |
| Jan 14, 2026 | Kyverna Therapeutics, Inc. (KYTX) | Grant/Award | 30,000 | n/a |
| Jun 6, 2025 | Beam Therapeutics Inc. (BEAM) | Grant/Award | 33,662 | n/a |
| Jun 2, 2025 | Kyverna Therapeutics, Inc. (KYTX) | Grant/Award | 16,634 | n/a |
| Feb 19, 2025 | Kyverna Therapeutics, Inc. (KYTX) | Grant/Award | 38,679 | n/a |
| Sep 19, 2024 | Kyverna Therapeutics, Inc. (KYTX) | Grant/Award | 66,592 | n/a |
| Jun 7, 2024 | Beam Therapeutics Inc. (BEAM) | Grant/Award | 23,114 | n/a |
| Dec 14, 2023 | Beam Therapeutics Inc. (BEAM) | Grant/Award | 39,046 | n/a |
| May 15, 2023 | Avantor, Inc. (AVTR) | Grant/Award | 9,808 | n/a |